Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides - PubMed (original) (raw)

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

F C Tenover et al. J Clin Microbiol. 1998 Apr.

Erratum in

Abstract

During the last several years a series of staphylococcal isolates that demonstrated reduced susceptibility to vancomycin or other glycopeptides have been reported. We selected 12 isolates of staphylococci for which the vancomycin MICs were > or =4 microg/ml or for which the teicoplanin MICs were > or =8 microg/ml and 24 control strains for which the vancomycin MICs were < or =2 microg/ml or for which the teicoplanin MICs were < or =4 microg/ml to determine the ability of commercial susceptibility testing procedures and vancomycin agar screening methods to detect isolates with reduced glycopeptide susceptibility. By PCR analysis, none of the isolates with decreased glycopeptide susceptibility contained known vancomycin resistance genes. Broth microdilution tests held a full 24 h were best at detecting strains with reduced glycopeptide susceptibility. Disk diffusion did not differentiate the strains inhibited by 8 microg of vancomycin per ml from more susceptible isolates. Most of the isolates with reduced glycopeptide susceptibility were recognized by MicroScan conventional panels and Etest vancomycin strips. Sensititre panels read visually were more variable, although with some of the panels MICs of 8 microg/ml were noted for these isolates. Vitek results were 4 microg/ml for all strains for which the vancomycin MICs were > or =4 microg/ml. Vancomycin MICs on Rapid MicroScan panels were not predictive, giving MICs of either < or =2 or > or =16 microg/ml for these isolates. Commercial brain heart infusion vancomycin agar screening plates containing 6 microg of vancomycin per ml consistently differentiated those strains inhibited by 8 microg/ml from more susceptible strains. Vancomycin-containing media prepared in-house showed occasional growth of susceptible strains, Staphylococcus aureus ATCC 29213, and on occasion, Enterococcus faecalis ATCC 29212. Thus, strains of staphylococci with reduced susceptibility to glycopeptides, such as vancomycin, are best detected in the laboratory by nonautomated quantitative tests incubated for a full 24 h. Furthermore, it appears that commercial vancomycin agar screening plates can be used to detect these isolates.

PubMed Disclaimer

Figures

FIG. 1

FIG. 1

Distribution of disk diffusion zone diameters of Staphylococcus species obtained with a 30-μg vancomycin disk or a 30-μg teicoplanin disk. Discrepant results are (a) an S. epidermidis (GSSS) isolate for which the teicoplanin zone diameter was 13 mm and the teicoplanin MIC was 4 μg/ml, (b) an S. epidermidis (GSSS) isolate for which the teicoplanin zone diameter was 15 mm and the teicoplanin MIC was 4 μg/ml, and (c) an S. aureus (GISA) isolate (isolate N20) for which the teicoplanin zone diameter was 17 mm and the teicoplanin MIC was 1 μg/ml.

FIG. 2

FIG. 2

PFGE patterns of _Sma_I-digested DNA from S. aureus isolates exhibiting reduced susceptibility to vancomycin. ATCC, S. aureus ATCC 29213; Std, molecular size standard.

Similar articles

Cited by

References

    1. Aarestrup F M, Ahrens P, Madsen M, Pallesen L V, Poulsen R L, Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother. 1996;40:1938–1940. - PMC - PubMed
    1. AB Biodisk America Inc. Etest package insert. Piscataway, N.J: AB Biodisk North America Inc.; 1996.
    1. Archer G L, Auger P, Doern G V, Ferraro M J, Fuchs P C, Jorgensen J H, Low D E, Murray P R, Reller L B, Stratton C W, Wennersten C B, Moellering R C., Jr RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis. 1993;16:223–226. - PubMed
    1. Bannerman T L, Hancock G A, Tenover F C, Miller J M. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol. 1995;33:551–555. - PMC - PubMed
    1. Barna J C, Williams D H. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol. 1984;38:339–357. - PubMed

MeSH terms

Substances

LinkOut - more resources